Thomas Hensing Department of Medicine Northshore University Health Systems Biography Publications Institution JoVE Articles Thomas Hensing has not added a biography. If you are Thomas Hensing and would like to personalize this page please email our Author Liaison for assistance. Publications A Brief Symptom Index for Advanced Lung Cancer Clinical Lung Cancer. Jan, 2012 | Pubmed ID: 21729652 Effect of an Electronic Health Record on the Culture of an Outpatient Medical Oncology Practice in a Four-hospital Integrated Health Care System: 5-year Experience Journal of Oncology Practice / American Society of Clinical Oncology. Jul, 2011 | Pubmed ID: 22043197 A Randomized Phase II Trial of First-line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Sep, 2011 | Pubmed ID: 21716146 Proteomic Characterization of Non-small Cell Lung Cancer in a Comprehensive Translational Thoracic Oncology Database Journal of Clinical Bioinformatics. Feb, 2011 | Pubmed ID: 21603121 Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Aug, 2011 | Pubmed ID: 21597387 Personalized Treatment of Lung Cancer Seminars in Oncology. Apr, 2011 | Pubmed ID: 21421117 Nanocytology for Field Carcinogenesis Detection: Novel Paradigm for Lung Cancer Risk Stratification Future Oncology (London, England). Jan, 2011 | Pubmed ID: 21174531 Optical Detection of Buccal Epithelial Nanoarchitectural Alterations in Patients Harboring Lung Cancer: Implications for Screening Cancer Research. Oct, 2010 | Pubmed ID: 20924114 A Multicenter Phase II Trial of Carboplatin and Cetuximab for Treatment of Advanced Nonsmall Cell Lung Cancer Cancer Investigation. Feb, 2010 | Pubmed ID: 19916742 Nanoscale Cellular Changes in Field Carcinogenesis Detected by Partial Wave Spectroscopy Cancer Research. Jul, 2009 | Pubmed ID: 19549915 Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab with Maintenance Pemetrexed and Bevacizumab As First-line Therapy for Nonsquamous Non-small-cell Lung Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2009 | Pubmed ID: 19433684 The Feasibility of Adjuvant Carboplatin and Docetaxel in Patients with Curatively Resected Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Feb, 2008 | Pubmed ID: 18303435 Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Feb, 2008 | Pubmed ID: 18303431 Relationship Between Symptom Change, Objective Tumor Measurements, and Performance Status During Chemotherapy for Advanced Lung Cancer Clinical Lung Cancer. Jan, 2008 | Pubmed ID: 18282359 Should Health-related Quality of Life Be Measured in Cancer Symptom Management Clinical Trials? Lessons Learned Using the Functional Assessment of Cancer Therapy Journal of the National Cancer Institute. Monographs. 2007 | Pubmed ID: 17951232 An Innovative Symptom Monitoring Tool for People with Advanced Lung Cancer: a Pilot Demonstration The Journal of Supportive Oncology. Sep, 2007 | Pubmed ID: 17944147 Treatment of Non-small Cell Lung Cancer, Stage IV: ACCP Evidence-based Clinical Practice Guidelines (2nd Edition) Chest. Sep, 2007 | Pubmed ID: 17873174 Third-generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: a Meta-analysis Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Sep, 2007 | Pubmed ID: 17805063 Phase I/II Study of Gemcitabine and Exisulind As Second-line Therapy in Patients with Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Mar, 2006 | Pubmed ID: 17409860 Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non-small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Jan, 2006 | Pubmed ID: 17409827 Phase II Study of BBR 3464 As Treatment in Patients with Sensitive or Refractory Small Cell Lung Cancer Anti-cancer Drugs. Jul, 2006 | Pubmed ID: 16917215 Efficacy and Safety of Gefitinib in Chemonaive Patients with Advanced Non-small Cell Lung Cancer Treated in an Expanded Access Program Lung Cancer (Amsterdam, Netherlands). Sep, 2006 | Pubmed ID: 16797779 Clinical Evaluation and Staging of Patients Who Have Lung Cancer Hematology/oncology Clinics of North America. Apr, 2005 | Pubmed ID: 15833404 A Phase II Trial of Weekly Paclitaxel and Gemctiabine Infused at a Constant Rate in Patients with Advanced Non-small Cell Lung Cancer Lung Cancer (Amsterdam, Netherlands). Mar, 2005 | Pubmed ID: 15713525 Factors Associated with the Likelihood of Receiving Second Line Therapy for Advanced Non-small Cell Lung Cancer Lung Cancer (Amsterdam, Netherlands). Feb, 2005 | Pubmed ID: 15639724 Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-stage Small-cell Lung Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Dec, 2004 | Pubmed ID: 15570087 Induction and Concurrent Chemotherapy with High-dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non-small-cell Lung Cancer: a Dose-escalation Phase I Trial Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2004 | Pubmed ID: 15514375 Indications for Lymphatic Mapping and Sentinel Lymphadenectomy in Patients with Thin Melanoma (Breslow Thickness < or =1.0 Mm) Annals of Surgical Oncology. Oct, 2004 | Pubmed ID: 15383424 Duration of Therapy in Advanced, Metastatic Non-small-cell Lung Cancer Clinical Advances in Hematology & Oncology : H&O. Jan, 2003 | Pubmed ID: 16227958 The Impact of Age on Toxicity, Response Rate, Quality of Life, and Survival in Patients with Advanced, Stage IIIB or IV Nonsmall Cell Lung Carcinoma Treated with Carboplatin and Paclitaxel Cancer. Aug, 2003 | Pubmed ID: 12910523 Clinical Applications of Proton MR Spectroscopy in Oncology Technology in Cancer Research & Treatment. Feb, 2002 | Pubmed ID: 12614173 Поколение комплексного грудной База данных Онкология - Инструмент для трансляционных исследований Mosmi Surati1, Matthew Robinson2, Suvobroto Nandi2, Leonardo Faoro2, Carley Demchuk2, Rajani Kanteti2, Benjamin Ferguson1, Tara Gangadhar2, Thomas Hensing3, Rifat Hasina2, Aliya Husain4, Mark Ferguson5, Theodore Karrison6, Ravi Salgia2 1Pritzker School of Medicine, University of Chicago, 2Department of Medicine, University of Chicago, 3Department of Medicine, Northshore University Health Systems, 4Department of Pathology, University of Chicago, 5Department of Surgery, University of Chicago, 6Department of Biostatistics, University of Chicago JoVE 2414 Médecine
Поколение комплексного грудной База данных Онкология - Инструмент для трансляционных исследований Mosmi Surati1, Matthew Robinson2, Suvobroto Nandi2, Leonardo Faoro2, Carley Demchuk2, Rajani Kanteti2, Benjamin Ferguson1, Tara Gangadhar2, Thomas Hensing3, Rifat Hasina2, Aliya Husain4, Mark Ferguson5, Theodore Karrison6, Ravi Salgia2 1Pritzker School of Medicine, University of Chicago, 2Department of Medicine, University of Chicago, 3Department of Medicine, Northshore University Health Systems, 4Department of Pathology, University of Chicago, 5Department of Surgery, University of Chicago, 6Department of Biostatistics, University of Chicago JoVE 2414 Médecine